RUNX1 loss renders hematopoietic and leukemic cells dependent on interleukin-3 and sensitive to JAK inhibition

Fan AC., Nakauchi Y., Bai L., Azizi A., Nuno KA., Zhao F., Köhnke T., Karigane D., Cruz-Hernandez D., Reinisch A., Khatri P., Majeti R.

DOI

10.1172/jci167053

Type

Journal

Journal of Clinical Investigation

Publisher

American Society for Clinical Investigation

Publication Date

15/08/2023

Permalink Original publication